IRCCS San Raffaele: Alzheimer Disease trials

The registry lists 10 Alzheimer Disease studies with IRCCS San Raffaele as lead sponsor. 8 are open to participants now and 0 have results posted.

No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Telerehabilitation in Alzheimer's DiseaseNot yet recruitingNCT07722169Not applicable
• Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)RecruitingNCT07720765
• Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease ProgressionRecruitingNCT07717567
• Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory ConcernsNot yet recruitingNCT07652931Not applicable
• Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica ResonanceNot yet recruitingNCT07456462Not applicable
• Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's DiseaseNot yet recruitingNCT07431255
• Neurocognitive Assessment Platform 4 AlzheimerRecruitingNCT07272811
• The Role of Advanced Electroencephalographic Data As Marker of Pathology and Prognosis in Primary DementiasEnrolling by invitationNCT06826157Not applicable
• PET Study of Acetylcholine Esterase Activity in Alzheimer's DiseaseCompletedNCT06180252
• PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration.CompletedNCT06179979